Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
fda
3
×
life sciences
national blog main
san francisco blog main
akouos
biogen
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alex azar
allergan
alliance for aging research
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
What
plans
3
×
drug
ipo
medicines
acquisitions
administration
affects
americans
angry
announced
anti
approved
benefited
bio
ceo
collabs
covid
daniel
date
deal
despite
developing
fda
fear
frequency
gilead
gilead’s
hearing
help
industry
introduce
losing
loss
meds
millions
month
o’day
pharma
presidential
price
Language
unset
Current search:
plans
×
fda
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans